Skip to main content

Peer Review reports

From: Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study

Original Submission
20 Jul 2022 Submitted Original manuscript
1 Nov 2022 Reviewed Reviewer Report
25 Nov 2022 Reviewed Reviewer Report
11 Dec 2022 Author responded Author comments - Jun Guo
Resubmission - Version 2
11 Dec 2022 Submitted Manuscript version 2
14 Dec 2022 Author responded Author comments - Jun Guo
Resubmission - Version 3
14 Dec 2022 Submitted Manuscript version 3
14 Dec 2022 Reviewed Reviewer Report
20 Dec 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
21 Dec 2022 Editorially accepted
6 Feb 2023 Article published 10.1186/s12885-022-10473-y

You can find further information about peer review here.

Back to article page